Immediate anticoagulation for acute stroke in atrial fibrillation: No

Stroke

Volumn 37, Issue 12, 2006, Pages 3054-3055

  Sandercock, Peter ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Atrial fibrillation

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; HEPARINOID; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; CANADA; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DRUG MEGADOSE; GERMANY; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL SPECIALIST; MEDICOLEGAL ASPECT; NEUROLOGIST; PRIORITY JOURNAL; SECONDARY PREVENTION; SHORT SURVEY; STROKE; UNITED KINGDOM; UNITED STATES;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; TIME FACTORS;

EID: 33845434638     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000248924.00226.77     Document Type: Short Survey

References (9)

1. Hart RG, Palacio S, Pearce LA. Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials. Stroke. 2002;33:2722-2727.
2. Moussouttas MM, Lichtman JH, Krumholtz HM, Cerese J, Brass L. The use of heparin anticoagulation in acute ischemic stroke among academic medical centers. Stroke. 1999;30:265.
3. Al Sadat A, Sunbulli M, Chaturvedi S. Use of intravenous heparin by North American neurologists: do the data matter? Stroke. 2002;33:1574-1577.
4. Kudesia R, Chaturvedi S. Practice variation among Michigan neurologists in the use of intravenous heparin. J Neurol Sci. 2002;202:25-27.
5. Daffertshofer M, Grips E, Dempfle CE, Hennerici M. Heparin during acute ischemic stroke. Present data and clinical situation. [German]. Nervenarzt. 2003;74:307-319.
6. Grips E, Daffertshofer M, Hennerici M. Banning anticoagulation in stroke or consequence of poor study design. Stroke. 2003;34:837-839.
7. Moonis M, Fisher M. Considering the role of heparin and low-molecularweight heparins in acute ischemic stroke. Stroke. 2002;33:1927-1933.
8. Coull BM, Williams LS, Goldstein LB, Meschia JF, Heitzman D, Chaturvedi S, Johnston KC, Starkman S, Morgenstern LB, Wilterdink JL, Levine SR, Saver JL; Joint Stroke Guideline Development Committee of the American Academy of Neurology/American Stroke Association. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke. 2002;33:1934-1942.
9. Lindley R, Amayo EO, Marshall J, Sandercock P, Dennis MS, Warlow CP. Acute stroke treatment in UK hospitals: the Stroke Association survey of consultant opinion. J R Coll Physicians Lond. 1995;29:479-484.